Core Scientific, Inc.
CORZ
$19.63
-$0.16-0.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -23.33% | -160.25% | 155.14% | 67.79% | -16.39% |
| Total Depreciation and Amortization | -9.36% | -15.63% | -73.70% | -35.53% | -23.20% |
| Total Amortization of Deferred Charges | 3.29% | -3.29% | -5.45% | 5.98% | -472.47% |
| Total Other Non-Cash Items | 27.20% | 178.34% | -172.61% | -90.92% | 4.92% |
| Change in Net Operating Assets | -59.88% | 274.81% | 678.37% | 15,075.91% | 432.81% |
| Cash from Operations | -155.67% | 654.78% | 1,008.79% | 2,206.69% | 2,723.92% |
| Capital Expenditure | -365.88% | -363.47% | -855.58% | -684.28% | -3,768.55% |
| Sale of Property, Plant, and Equipment | -22.32% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 98.91% | -27.50% | -15,239.39% | 100.00% |
| Cash from Investing | -565.71% | -334.36% | -849.11% | -714.21% | -3,656.53% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3,121.13% | 75.47% | 95.23% | 99.79% | -99.33% |
| Issuance of Common Stock | -- | -69.55% | 73.79% | -27.81% | -- |
| Repurchase of Common Stock | -5,038.72% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -9,415.76% | -- | -- | -- | -- |
| Cash from Financing | 7,089.09% | 23,239.16% | -103.65% | -102.92% | -109.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,297.31% | 703.67% | -124.36% | -181.62% | -583.59% |